Ametek

AME

Market cap $54.8B

Examine Ametek's (AME) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

BERWYN, Pa., Feb. 12, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced its Board of Directors has approved a 10% increase in its quarterly cash dividend on common stock to $0.34 per share from $0.31 per share.

The Zacks Electronics -Testing Equipment industry players, such as AME, FTV and CGNX, are poised to benefit from the solid demand for testing instruments.

AME beats Q4 estimates as earnings rise 7.5% Y/Y and revenues jump 13.4%, driven by solid growth across both operating segments.

AMETEK delivered strong Q4 2025 results, exceeding analyst expectations on revenue and earnings, and forecasts continued mid-to-high single-digit growth in 2026. AME's growth remains driven by strategic acquisitions, robust organic performance in the Electromechanical Group, and disciplined capital allocation with low net leverage. Despite operational excellence and future growth prospects, AME trades at elevated valuation multiples versus peers, limiting upside for new investors.

AMETEK, Inc. (AME) Q4 2025 Earnings Call Transcript

The headline numbers for Ametek (AME) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Ametek (AME) came out with quarterly earnings of $2.01 per share, beating the Zacks Consensus Estimate of $1.94 per share. This compares to earnings of $1.87 per share a year ago.

TORONTO and PARK CITY, Utah, Feb. 3, 2026 /PRNewswire/ -- DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, today announces the sale of LKC Technologies to AMETEK, Inc. (NYSE: AME). As leaders in the world of visual electrophysiology, LKC Technologies, a portfolio company of DW Healthcare Partners' Founders Fund, is dedicated to preserving sight by expanding access to objective functional retinal assessments.

BERWYN, Pa., Feb. 3, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced the acquisition of LKC Technologies, a leading provider of innovative technologies to enable the effective diagnosis and management of ophthalmic conditions.